CNBC Investing Club

Investing Club: We're capitalizing on one of our drug stocks' incredible run, selling some shares

Traders work on the floor of the New York Stock Exchange.
NYSE

We're selling 200 shares of Abbvie (ABBV) at roughly $147.65. Following the trade, we'll own 700 shares of ABBV, decreasing its weighting to 2.68% from 3.42%.

More In CNBC Investing Club Newsletter

Ford CEO surprised by F-150 Lightning backup power popularity. It's a game changer
CNBC Investing ClubFord CEO surprised by F-150 Lightning backup power popularity. It's a game changer
We understand why Salesforce's Benioff went to such great lengths to keep co-CEO Taylor
CNBC Investing ClubWe understand why Salesforce's Benioff went to such great lengths to keep co-CEO Taylor
Jim Cramer's Investing Club meeting Thursday: Fed caution, trimming a retailer, Humana guidance
CNBC Investing ClubJim Cramer's Investing Club meeting Thursday: Fed caution, trimming a retailer, Humana guidance